CSRC Executive Committee member and Scientific Programs Committee Chair Jonathan Seltzer, MD, MBA, MA, attended the inaugural 2018 CEC Summit on September 26-27, 2018. This event, cohosted by the Duke Clinical Research Institute and Stanford Center for Clinical Research, brought together thought leaders from academia, industry, and government to establish consistent standards globally for clinical events classification (CEC) and adjudication in clinical trials.
“This meeting was special as it examined both the scientific justification for endpoint adjudication as well as operational best practices. It is likely that future meetings with this group will deliver innovative solutions to issues whereby adjudication strategies can be more broadly applied, but in an intelligent, cost-effective manner,” said Seltzer, who also serves as the president and CEO of ACI Clinical.
Event panelists and speakers represented various organizations including the U.S. Food and Drug Administration (FDA), Harvard University, Cleveland Clinic, George Clinical, the Cardiovascular Research Foundation, Cardialysis, and more.
Hear what others had to say about the event and find a recap of the summit here.